Azithromycin for Preventing Maternal and Neonatal Infections During Labor.
NCT ID: NCT06958146
Last Updated: 2025-05-06
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
PHASE4
400 participants
INTERVENTIONAL
2025-05-01
2025-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Azithromycin-Prevention in Labor Use Study (A-PLUS)
NCT03871491
Antibiotic Prophlaxis for High-risk Laboring Women in Low Income Countries
NCT03248297
Pre-delivery Administration of Azithromycin to Prevent Neonatal Sepsis & Death
NCT03199547
Azithromycin Prophylaxis for PRElabor CEsarean DElivery Trial
NCT06605118
Azithromycin Before Induction
NCT06543290
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
pregnanct ladies in labor receiving single dose azithromycin along with standard labor care
The participants in this arm will receive a single dose of 2 g oral azithromycin along with standard care in the intrapartum period
oral azithromycin
we will be administering single-dose oral azithromycin to ladies who go into labor and have no risk factors for sepsis, as there is increased risk of postpartum sepsis in both mother and neonate after normal vaginal delivery in low-income and middle-income countries
Pregnant ladies in labor receiving only standard care and no oral azithromycin
participants in this arm will be given only standard labor care and no antibiotics
no azithromycin
participants in this arm will be given only standard labor care and no oral azithromycin
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
oral azithromycin
we will be administering single-dose oral azithromycin to ladies who go into labor and have no risk factors for sepsis, as there is increased risk of postpartum sepsis in both mother and neonate after normal vaginal delivery in low-income and middle-income countries
no azithromycin
participants in this arm will be given only standard labor care and no oral azithromycin
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
45 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Armed Forces Hospital, Pakistan
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
arshad khushdil
professor
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Azithromycin 2025
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.